[HTML][HTML] An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo …

G Kiru, C Bicknell, E Falaschetti, J Powell… - Health Technology …, 2016 - europepmc.org
Background Although data are inconsistent, angiotensin-converting enzyme inhibitors (ACE-
Is) have been associated with a reduced incidence of abdominal aortic aneurysm (AAA) …

An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled …

CD Bicknell, G Kiru, E Falaschetti… - European heart …, 2016 - academic.oup.com
Aims The AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition
on RisK) trial investigated whether ACE-inhibition reduces small abdominal aortic …

[HTML][HTML] Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms

MJ Sweeting, SG Thompson, LC Brown… - Journal of vascular …, 2010 - Elsevier
OBJECTIVES: To evaluate whether either angiotensin converting enzyme (ACE) inhibitors
or other classes of antihypertensive drug attenuate or increase growth rates of small …

Systematic review examining the association of angiotensin converting enzyme inhibitor and angiotensin receptor blocker prescription with abdominal aortic …

K Tian, S Thanigaimani, K Gibson… - European Journal of …, 2024 - Elsevier
Objective Whether angiotensin II blockade is an effective medical treatment for abdominal
aortic aneurysms (AAAs) has not been established. This systematic review and meta …

Pathogenesis and management of abdominal aortic aneurysm

J Golledge, S Thanigaimani, JT Powell… - European Heart …, 2023 - academic.oup.com
Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …

Multicentre study of abdominal aortic aneurysm measurement and enlargement

FA Lederle, S Noorbaloochi, S Nugent… - Journal of British …, 2015 - academic.oup.com
Background No effective treatment is currently available to prevent progression of small and
medium-sized abdominal aortic aneurysms (AAAs). Identification of drugs with sufficient …

Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study: metformin and angiotensin-converting enzyme …

C Gellatly, M Sweeting, A Emin… - British Journal of …, 2024 - academic.oup.com
Background There is a clinical need for treatments that can slow or prevent the growth of an
abdominal aortic aneurysm, not only to reduce the need for surgery, but to provide a means …

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study

KE Kristensen, C Torp-Pedersen… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—The renin–angiotensin system is thought to play a pivotal role in the
pathogenesis of abdominal aortic aneurysms (AAAs). However, effects of angiotensin …

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study

DG Hackam, D Thiruchelvam, DA Redelmeier - The Lancet, 2006 - thelancet.com
Background Angiotensin-converting enzyme (ACE) inhibitors prevent the expansion and
rupture of aortic aneurysms in animals. We investigated the association between ACE …

Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost …

S Thompson, L Brown, M Sweeting… - Health …, 2013 - researchonline.lshtm.ac.uk
BACKGROUND Small abdominal aortic aneurysms (AAAs; 3.0-5.4 cm in diameter) are
usually asymptomatic and managed by regular ultrasound surveillance until they grow to a …